Contents
On this page
- The headache finding: measures and study population
- Skin irritation and the respiratory finding in chronic obstructive pulmonary disease (COPD)
- Greater caution for proposed mechanisms than for documented outcomes
- A related but distinct finding: disposable masks and plastic pollution
- Psychological and behavioral dimensions and the need for equivalent rigor
- A model for responsible reporting to a patient audience
Academy · Research Promotion · Communicating Mask-Use Evidence
Evidence on Prolonged Mask Use: A Model for Accurate Patient-Facing Health Communication
A 2020 survey-based study found that headache was the most commonly reported side effect of prolonged mask use among healthcare workers, a documented and moderate effect. Responsible reporting of this finding for patients requires the actual study design and sample to be stated, so that a genuine finding is not read as a sweeping health warning.
Writing patient-facing material about a documented but narrow finding, such as the physical effects of prolonged mask use, is a specific skill distinct from writing the underlying research itself: it requires stating what a study found, in whom and under what conditions, clearly enough that a general reader neither dismisses a real effect nor assumes that it applies more broadly than the evidence supports. The literature on prolonged mask use during the COVID-19 pandemic is a useful worked example precisely because it contains a small number of well-documented findings, most prominently headache and facial skin irritation, surrounded by a much larger volume of less rigorous claims. This makes it a useful test case for the discipline that patient communication requires: stating exactly what was shown and in which population, without extending it beyond what the data support.
Learning objectives
- The best-documented physical effects of prolonged mask use and the specific studies and populations on which they are based
- The reasons population-specific findings, such as those in healthcare workers or patients with COPD, should not be generalized without qualification
- A practical model for writing patient-facing material that states findings precisely without alarming or dismissing readers
Common misconceptions
- “If a study found an effect in one population, it's reasonable to describe it as a general risk of mask use in patient materials.” The study by Kyung and colleagues of N95 mask use in subjects with COPD, published in Respiratory Care in 2020, documented specific physiological changes in that particular patient group under N95-specific conditions. Presenting this finding to a general patient audience as a universal risk of any mask in any wearer would misstate a finding specific to a population and a mask type as a general one.
The headache finding: measures and study population
The most robustly documented physical effect of prolonged mask use during the pandemic is headache among people who wear personal protective equipment, including masks, for extended periods at work, most thoroughly studied in healthcare workers. Ong and colleagues' 2020 study, published in Headache, surveyed healthcare workers using personal protective equipment and found that a majority of respondents who wore masks for prolonged periods reported new-onset or worsened headache, with the severity and duration linked to how long the equipment was worn continuously1. This is a genuine, survey-documented finding, and it is specific in two important respects that a patient-facing summary must preserve: the population studied was healthcare workers wearing PPE for extended clinical shifts, not the general public wearing a mask intermittently for shopping or transit, and the measure was self-reported headache via survey rather than a clinically diagnosed headache disorder, both of which determine how far the finding can reasonably be generalized1.
Skin irritation and the respiratory finding in chronic obstructive pulmonary disease (COPD)
Facial skin irritation from prolonged mask wear, popularly termed "maskne," is a second well-documented effect, with dermatological literature describing a combination of occlusion, friction, and altered local microbiome balance under the mask as contributing mechanisms, and prevalence studies finding a meaningful proportion of regular mask wearers reporting some degree of acne, irritation, or breakdown specifically in the area the mask covers2. A separate and more clinically specific finding comes from Kyung and colleagues' study of N95 respirator use in patients with chronic obstructive pulmonary disease, published in Respiratory Care in 2020, which measured physiological changes, including small increases in resistance to airflow, specifically in this patient group wearing N95-grade respirators under controlled conditions3. This finding is specific to N95 respirators, not cloth or standard surgical masks, and specific to patients with pre-existing lung disease, two constraints that materially change what the finding actually supports if restated for a general audience.
Greater caution for proposed mechanisms than for documented outcomes
A distinction patient communication needs to hold onto carefully is between a documented outcome (what a study actually measured and found) and a proposed mechanism offered to explain it (such as claims about carbon dioxide rebuilding under a mask, which have been studied with more mixed and context-dependent results than the headache or skin-irritation findings themselves). Scheid and colleagues' 2020 commentary in the International Journal of Environmental Research and Public Health reviews the physiological and psychological evidence on mask-wearing and is explicit that many proposed mechanisms require more rigorous, controlled measurement before being stated as established facts, even where the downstream symptom, such as headache or discomfort, is itself well documented4. An earlier, smaller study by Roberge and colleagues measuring the physiological impact of N95 respirators on healthcare workers similarly found some measurable changes in blood gas values under controlled conditions, but the effects were modest and the authors did not conclude that healthy adult wearers faced a meaningful respiratory risk from short- to moderate-duration use, a caveat that should be preserved alongside the principal physiological finding rather than omitted6. None of this body of evidence on side effects contradicts the separate, much larger evidence base on whether masks reduce respiratory virus transmission; a 2023 Cochrane review of physical interventions to reduce respiratory virus spread, and public health guidance from the WHO and CDC, address that separate protective-benefit question, which patient material on side effects should reference but not attempt to re-adjudicate on its own789. Patient-facing material that states a documented symptom as fact while treating its proposed underlying mechanism with appropriate caution, rather than presenting both with equal certainty, is both more accurate and, over time, more trustworthy to a reader who later encounters more complete evidence on the mechanism.
A related but distinct finding: disposable masks and plastic pollution
A separate, genuinely documented finding sits alongside the physiological effects covered above: disposable masks, made primarily of polypropylene and other plastic polymers, became a measurable new source of plastic and microplastic pollution during the pandemic, as environmental science literature on pandemic-related waste has documented through direct sampling of discarded masks and their breakdown products in waterways and coastal environments5. This is a distinct category of finding from the physiological effects on wearers, an environmental and waste-management issue rather than a health effect experienced by the person wearing the mask, and patient-facing material should keep the two separate rather than blending an environmental concern into a list of personal health risks, or vice versa, since conflating them obscures both the health guidance and the environmental guidance.
Psychological and behavioral dimensions and the need for equivalent rigor
Scheid and colleagues' 2020 commentary also reviews psychological effects reported in connection with mask-wearing, including discomfort, claustrophobic sensations, and difficulty reading facial expressions and emotional cues from others, noting that evidence on these effects is generally drawn from smaller studies and self-report measures with their own limitations, similar in kind to the limitations affecting the physiological literature discussed above4. The same discipline that applies to physiological claims applies here: a patient-facing summary should state that some wearers report discomfort or difficulty with social communication cues, note that the evidence is largely self-report based rather than drawn from standardized clinical instruments, and avoid extending findings from, for example, studies of healthcare workers in extended clinical shifts to brief, intermittent public mask use, which is a meaningfully different exposure. Patient materials addressing this dimension are also well served by acknowledging that psychological response to mask-wearing is itself likely to vary by individual history and context, including prior experience with claustrophobia or anxiety, rather than presenting a single expected psychological reaction as though it applied uniformly to all wearers.
A model for responsible reporting to a patient audience
A workable model for this kind of patient communication states four things for every finding included: what was measured, in whom, under what conditions, and what practical action follows. Applied to the headache finding, the model yields the following: healthcare workers wearing PPE continuously for extended shifts reported headache at meaningfully elevated rates in a 2020 survey study; the practical action is building in scheduled breaks from continuous mask wear where clinically and operationally feasible, not avoiding masks altogether1. Applied to the COPD-specific finding, it yields the following: patients with COPD using N95 respirators showed measurable changes in airflow resistance in a controlled study; the practical action is that patients with COPD should discuss N95 use specifically, as opposed to other mask types, with their own clinician rather than generalizing advice intended for the broader public3. This four-part structure, measured/population/conditions/action, is reusable well beyond mask-use communication for any patient material built from a narrow but genuine research finding. Applied to the environmental finding, the same discipline holds: disposable masks have been documented as a contributor to plastic and microplastic pollution during the pandemic, and the practical, proportionate action communicated to the public is support for better waste-management and disposal infrastructure, or a shift toward washable cloth masks where clinically appropriate, rather than a recommendation to avoid masks that would undercut the separate, well-documented protective benefit masks provide against respiratory disease transmission.
Key points
Key points
The best-documented physical effects of prolonged mask use, namely headache in healthcare workers wearing personal protective equipment (PPE) and specific airflow changes in patients with COPD using N95 respirators, are genuine but specific to population and mask type. Responsible reporting for patients requires stating what was measured, in whom and under what conditions, and keeping documented outcomes distinct from less settled proposed mechanisms.
Practical application
Practical application
- The population and mask type should be stated for every finding cited. A finding from healthcare workers in PPE, or from N95 users with COPD, should never be generalized to a blanket statement about “masks” without naming the specific population and mask type covered by the underlying study.
- Documented outcomes should be distinguished from proposed mechanisms. A measured symptom (such as headache) should be stated as a finding, whereas an unconfirmed explanatory mechanism (such as a specific physiological pathway) should be identified as still under investigation, rather than both being presented with the same certainty.
- A four-part structure should be applied to every patient-facing claim: what was measured, the population, the conditions and the recommended action. This structure prevents a genuine but narrow finding from becoming an overgeneralized warning or an overstated reassurance as it moves from the research literature into patient-facing material.
Frequently asked questions
The best-documented study on this, Ong and colleagues' 2020 survey, specifically covered healthcare workers wearing PPE continuously for extended shifts; it is a real, well-documented finding in that population, but patient material should state that population specifically rather than implying the same rate applies to anyone wearing a mask briefly or intermittently.
No. Kyung and colleagues' study specifically measured N95 respirator use in COPD patients; it does not establish the same finding for cloth or standard surgical masks, which have different filtration and breathing-resistance properties, so this distinction should be stated explicitly in any patient-facing summary.
Scheid and colleagues' 2020 review found the evidence on this specific mechanism more mixed and context-dependent than the documented symptom-level findings like headache and skin irritation, and recommends treating mechanism-level claims with more caution than clearly measured outcomes until better-controlled studies are available.
Both failure modes are real: overstating a narrow finding as universal can cause unnecessary anxiety or mask avoidance in contexts where masks remain genuinely protective, while dismissing a genuinely documented effect like headache in healthcare workers can leave a real, addressable problem (like insufficient break scheduling) unaddressed; stating population, conditions, and practical action precisely is what avoids both.
References
- Ong JJY, Bharatendu C, Goh Y, et al. Headaches Associated With Personal Protective Equipment — A Cross-Sectional Study Among Frontline Healthcare Workers During COVID-19. Headache. 2020;60(5):864-877. read 10 October 2026. View on Headache (Wiley)
- Teo WL. The 'Maskne' Microbiome — Pathophysiology and Therapeutics. Int J Dermatol. 2021;60(5):554-557. read 10 October 2026. View on International Journal of Dermatology
- Kyung SY, Kim Y, Hwang H, Park JW, Jeong SH. Risks of N95 Face Mask Use in Subjects With COPD. Respir Care. 2020;65(5):658-664. read 10 October 2026. View on Respiratory Care
- Scheid JL, Lupien SP, Ford GS, West SL. Commentary: Physiological and Psychological Impact of Face Mask Usage during the COVID-19 Pandemic. Int J Environ Res Public Health. 2020;17(18):6655. read 10 October 2026. View on IJERPH
- Fadare OO, Okoffo ED. Covid-19 face masks: A potential source of microplastic fibers in the environment. Sci Total Environ. 2020;737:140279. read 10 October 2026. View on Science of the Total Environment
- Roberge RJ, Coca A, Williams WJ, Powell JB, Palmiero AJ. Physiological impact of the N95 filtering facepiece respirator on healthcare workers. Respir Care. 2010;55(5):569-577. read 10 October 2026. View on Respiratory Care
- World Health Organization. Advice on the use of masks in the context of COVID-19: Interim guidance. read 10 October 2026. View WHO mask guidance
- Centers for Disease Control and Prevention. Types of Masks and Respirators. read 10 October 2026. View CDC mask guidance
- Jefferson T, Dooley L, Ferroni E, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev. 2023;(1):CD006207. read 10 October 2026. View on Cochrane Database of Systematic Reviews
- Chughtai AA, Seale H, MacIntyre CR. Effectiveness of Cloth Masks for Protection Against Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis. 2020;26(10):e200948. read 10 October 2026. View on Emerging Infectious Diseases
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 10). Evidence on Prolonged Mask Use: A Model for Accurate Patient-Facing Health Communication. Pubrica. https://pubrica.com/academy/physician-writing/causes-of-prolonged-use-of-masks-during-covid-19-pandemic/
Pubrica Academy. “Evidence on Prolonged Mask Use: A Model for Accurate Patient-Facing Health Communication.” Pubrica, 10 Oct. 2026, pubrica.com/academy/physician-writing/causes-of-prolonged-use-of-masks-during-covid-19-pandemic/.
Pubrica Academy (2026) Evidence on Prolonged Mask Use: A Model for Accurate Patient-Facing Health Communication. Pubrica. Available at: https://pubrica.com/academy/physician-writing/causes-of-prolonged-use-of-masks-during-covid-19-pandemic/ (Accessed: 15 October 2026).
Pubrica Academy. “Evidence on Prolonged Mask Use: A Model for Accurate Patient-Facing Health Communication.” Pubrica. October 10, 2026. https://pubrica.com/academy/physician-writing/causes-of-prolonged-use-of-masks-during-covid-19-pandemic/
Pubrica Academy, ‘Evidence on Prolonged Mask Use: A Model for Accurate Patient-Facing Health Communication’ (Pubrica, 10 October 2026) <https://pubrica.com/academy/physician-writing/causes-of-prolonged-use-of-masks-during-covid-19-pandemic/> accessed 15 October 2026.
Pubrica Academy. Evidence on Prolonged Mask Use: A Model for Accurate Patient-Facing Health Communication. [Internet]. Pubrica; 2026 Oct 10 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/physician-writing/causes-of-prolonged-use-of-masks-during-covid-19-pandemic/
Pubrica Academy, “Evidence on Prolonged Mask Use: A Model for Accurate Patient-Facing Health Communication,” Pubrica, Oct. 10, 2026. [Online]. Available: https://pubrica.com/academy/physician-writing/causes-of-prolonged-use-of-masks-during-covid-19-pandemic/
@misc{/la_communicating_evidence_prolonged_mask_use_2026,
author = {{Pubrica Academy}},
title = {Evidence on Prolonged Mask Use: A Model for Accurate Patient-Facing Health Communication},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/physician-writing/causes-of-prolonged-use-of-masks-during-covid-19-pandemic/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Patient-Facing Finding Summary Template
This four-part structure should be applied before any narrow research finding is written up for a general patient audience.
[ ] What was measured: the specific symptom, outcome, or physiological change recorded [ ] In whom: the exact population studied (not the general public unless that is genuinely who was studied) [ ] Under what conditions: mask type, duration, setting, and any other condition-specific detail [ ] What practical action follows: a specific, proportionate recommendation, not a blanket warning or blanket reassurance [ ] Checked that any proposed mechanism is clearly flagged as less certain than the documented outcome itself
Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
Pubrica’s patient communication and medical writing team converts narrow, population-specific research findings into accurate, proportionate patient-facing material, stating precisely what was measured and in whom so that a genuine finding is not overgeneralized.